+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Non-vascular Stents Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968585
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Non-vascular Stents Market is projected to reach USD 2.03 Billion in 2026. It is expected to continue growing at a CAGR of 6.13%, reaching USD 2.91 Billion by 2032.

Non-vascular stents are critical implantable devices used to restore or preserve lumen patency outside the vascular system, including the biliary tract, gastrointestinal tract, airway, ureter, pancreas, prostate, and esophagus. Demand is supported by the documented clinical burden of cancer, benign strictures, stone disease, chronic obstructive pulmonary disease, and age-related obstruction, all of which are recognized priorities across WHO, GLOBOCAN, OECD, and national health system datasets.

The non-vascular stents market is moving from purely mechanical palliation toward procedure-enabling, image-guided, and increasingly customized solutions. Self-expanding metal stents, covered stents, polymeric devices, anti-migration designs, and biodegradable platforms are reshaping care pathways by reducing repeat interventions and supporting less invasive treatment across endoscopy, interventional pulmonology, and urology.

Transformative Shifts in the Non-Vascular Stents Landscape

The non-vascular stents landscape is being transformed by three structural forces: minimally invasive care, material innovation, and tighter evidence expectations. Hospitals are prioritizing endoscopic and image-guided procedures that can shorten length of stay and reduce open surgical risk, while device developers are improving radial force, conformability, migration resistance, removability, and drug compatibility.

Clinical practice is also shifting toward indication-specific devices rather than one-size-fits-all stents. Biliary stents are benefiting from advances in covered metal designs, airway stents from silicone and hybrid configurations, and urological stents from coatings designed to reduce encrustation and infection risk. Regulatory agencies are simultaneously emphasizing clinical performance, biocompatibility, post-market surveillance, and real-world evidence, making data quality a core competitive advantage.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the non-vascular stents ecosystem, beginning with diagnosis and case selection. AI-enabled imaging workflows can support the detection of strictures, obstruction, tumor burden, stone-related complications, and airway narrowing, helping clinicians plan device size, placement route, and follow-up protocols with greater consistency.

AI is also influencing product development and operations. Machine learning can accelerate finite element modeling, fatigue testing simulations, coating optimization, adverse event signal detection, inventory planning, and physician training analytics. While AI does not replace clinical judgment, its integration into imaging, navigation, manufacturing quality systems, and real-world data analysis is expected to improve procedural planning and reduce avoidable variation in stent performance.

Key Regional Insights

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in endoscopy capacity, oncology care, and minimally invasive urology. Large patient pools, rising cancer diagnosis, gallstone disease, and broader insurance coverage are increasing demand for biliary, esophageal, ureteral, and airway stents, while local manufacturing strengthens price competition and availability.

North America remains a high-value region due to advanced hospital infrastructure, strong adoption of interventional endoscopy and pulmonology, and established FDA and Health Canada pathways for device safety and surveillance. Europe benefits from mature reimbursement systems, specialist centers, and EU Medical Device Regulation requirements that raise evidence standards. Latin America shows improving adoption through private hospital networks and oncology access improvements, led by Brazil and Mexico. The Middle East is supported by tertiary care investments, particularly across GCC countries, while Africa remains an access-led opportunity where specialist availability, procurement funding, referral infrastructure, and training capacity shape adoption.

Key Group Insights

ASEAN demand is being driven by healthcare infrastructure upgrades in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, with endoscopy and urology access improving unevenly across public and private systems. The GCC is characterized by premium tertiary hospitals, high medical technology adoption, and centralized procurement, especially in Saudi Arabia and the United Arab Emirates, where oncology, gastroenterology, and urology services are expanding.

The European Union offers a large regulated environment where MDR compliance, clinical evidence, traceability, and notified body capacity influence launch timelines and product continuity. BRICS countries combine large disease burden with expanding local manufacturing and cost-sensitive procurement, making value-based product positioning essential. G7 markets remain innovation-led and reimbursement-sensitive, with strong emphasis on clinical outcomes and post-market evidence, while NATO countries overlap with many advanced healthcare systems that emphasize supply chain resilience, cybersecurity, and continuity of medical device availability.

Key Country Insights

The United States leads in premium non-vascular stent adoption because of advanced procedural capacity, strong specialty society guidance, and established reimbursement for endoscopic, pulmonary, and urologic interventions. Canada emphasizes evidence-based access across provincial systems, while Mexico and Brazil are expanding demand through private hospitals, urban specialty centers, and improving oncology and gastroenterology services.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine aging populations with established endoscopy networks, though MDR compliance, health technology assessment expectations, and hospital budget controls affect purchasing cycles. Russia remains influenced by localization and public procurement policy. In Asia-Pacific, China and India are scale markets with rising cancer, gastrointestinal disease, and urological obstruction management needs; Japan and South Korea are innovation-focused with sophisticated clinical practice and advanced endoscopic capability; and Australia maintains high standards for device evaluation, specialist access, and clinical governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize evidence generation, differentiated design, and reliable supply. Clinical data demonstrating lower migration, reduced reintervention, improved patency, and safe removability can strengthen market access discussions with hospitals, payers, and regulators.

Manufacturers should invest in indication-specific portfolios, AI-supported design validation, coating technologies, physician education, and post-market surveillance. Commercial teams should align products with regional reimbursement realities, expand training in emerging markets, and build resilient sourcing strategies for nitinol, silicone, polymers, delivery systems, and sterilization capacity.

Research Methodology

This executive summary is based on secondary research from public health agencies, regulatory guidance, peer-reviewed clinical literature, hospital technology trends, and public disclosures related to non-vascular stents. Sources considered include WHO, GLOBOCAN, FDA, European Commission MDR materials, OECD health indicators, national health statistics, and specialty society publications in gastroenterology, pulmonology, and urology.

The analysis applies triangulation across disease burden, procedure adoption, reimbursement trends, regulatory requirements, product innovation, and regional healthcare infrastructure. Insights are synthesized qualitatively to support strategic decision-making without relying on unverified market sizing, market share, or forecasting claims.

Conclusion

The non-vascular stents market is positioned for continued relevance as healthcare systems expand minimally invasive treatment for malignant and benign obstruction. Clinical demand is broad, spanning gastroenterology, urology, pulmonology, and oncology, while product competition increasingly depends on performance evidence and procedure-specific design.

Organizations that combine strong clinical validation, AI-enabled development, regional market access discipline, and dependable manufacturing will be best positioned to address demand across mature and emerging healthcare systems. The next phase of competition will favor devices that improve patency, reduce complications, and support efficient care delivery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-vascular Stents Market, by Product Type
7.1. Introduction
7.2. Balloon-Expandable
7.3. Self-Expanding
8. Non-vascular Stents Market, by Material Type
8.1. Introduction
8.2. Nitinol
8.3. Polymeric
8.4. Stainless Steel
9. Non-vascular Stents Market, by Coverage Configuration
9.1. Introduction
9.2. Covered
9.3. Partially Covered
9.4. Uncovered
10. Non-vascular Stents Market, by Retrievability
10.1. Introduction
10.2. Retrievable
10.3. Non-Retrievable
11. Non-vascular Stents Market, by Construction Method
11.1. Introduction
11.2. Braided
11.3. Laser-Cut
11.4. Woven
12. Non-vascular Stents Market, by Clinical Indication
12.1. Introduction
12.2. Benign Strictures
12.3. Malignant Obstruction
12.4. Leaks And Fistulas
13. Non-vascular Stents Market, by Application
13.1. Introduction
13.2. Airway
13.2.1. Bronchial
13.2.2. Tracheal
13.3. Biliary
13.4. Gastrointestinal
13.4.1. Colorectal
13.4.2. Duodenal
13.4.3. Esophageal
13.5. Urological
13.5.1. Prostatic
13.5.2. Ureteral
13.5.3. Urethral
14. Non-vascular Stents Market, by End User
14.1. Introduction
14.2. Ambulatory Surgical Center
14.3. Hospitals
15. Non-vascular Stents Market, by Region
15.1. Asia-Pacific
15.2. Europe
15.3. North America
15.4. Latin America
15.5. Africa
15.6. Middle East
16. Non-vascular Stents Market, by Group
16.1. NATO
16.2. G7
16.3. BRICS
16.4. European Union
16.5. ASEAN
16.6. GCC
17. Non-vascular Stents Market, by Country
17.1. China
17.2. United States
17.3. Japan
17.4. India
17.5. Germany
17.6. United Kingdom
17.7. Australia
17.8. France
17.9. South Korea
17.10. Italy
17.11. Canada
17.12. Russia
17.13. Brazil
17.14. Mexico
17.15. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. Allium Medical Solutions Ltd.
19.3. B. Braun Melsungen AG
19.4. Becton, Dickinson and Company
19.5. Boston Scientific Corporation
19.6. Changzhou Health Microport Medical Device Co., Ltd.
19.7. Coloplast A/S
19.8. CONMED Corporation
19.9. Cook Medical LLC
19.10. ELLA-CS, s.r.o.
19.11. Endo GI Medical Ltd.
19.12. Endo-Flex GmbH
19.13. Fujifilm Holdings Corporation
19.14. Glaukos Corporation
19.15. Hobbs Medical, Inc.
19.16. Hoya Corporation
19.17. M.I.Tech Co., Ltd.
19.18. Medi-Globe GmbH
19.19. Medtronic plc
19.20. Merit Medical Systems, Inc.
19.21. Micro-Tech (Nanjing) Co., Ltd.
19.22. Olympus Corporation
19.23. Optimed Medizinische Instrumente GmbH
19.24. Pentax Medical
19.25. S.B. Kawasumi Laboratories, Inc.
19.26. Stening SRL
19.27. Taewoong Medical Co., Ltd.
19.28. Teleflex Incorporated
19.29. Terumo Corporation
19.30. W. L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL NON-VASCULAR STENTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NON-VASCULAR STENTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NON-VASCULAR STENTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NON-VASCULAR STENTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL NON-VASCULAR STENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL NON-VASCULAR STENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NON-VASCULAR STENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BALLOON-EXPANDABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BALLOON-EXPANDABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BALLOON-EXPANDABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL SELF-EXPANDING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL SELF-EXPANDING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL SELF-EXPANDING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL NITINOL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL NITINOL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL NITINOL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL POLYMERIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL POLYMERIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL POLYMERIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL COVERED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL COVERED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL COVERED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PARTIALLY COVERED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PARTIALLY COVERED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL PARTIALLY COVERED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL UNCOVERED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL UNCOVERED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL UNCOVERED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL RETRIEVABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL RETRIEVABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL RETRIEVABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL NON-RETRIEVABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL NON-RETRIEVABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL NON-RETRIEVABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL BRAIDED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL BRAIDED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL BRAIDED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL LASER-CUT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL LASER-CUT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL LASER-CUT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL WOVEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL WOVEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL WOVEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL BENIGN STRICTURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL BENIGN STRICTURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BENIGN STRICTURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL MALIGNANT OBSTRUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL MALIGNANT OBSTRUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL MALIGNANT OBSTRUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL LEAKS AND FISTULAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL LEAKS AND FISTULAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL LEAKS AND FISTULAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL AIRWAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AIRWAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL AIRWAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL BRONCHIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL BRONCHIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL BRONCHIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TRACHEAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL TRACHEAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TRACHEAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL BILIARY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL BILIARY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL BILIARY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL GASTROINTESTINAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL GASTROINTESTINAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL GASTROINTESTINAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL COLORECTAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL COLORECTAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL COLORECTAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL DUODENAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL DUODENAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL DUODENAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ESOPHAGEAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ESOPHAGEAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ESOPHAGEAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL UROLOGICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL UROLOGICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL UROLOGICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PROSTATIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PROSTATIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PROSTATIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL URETERAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL URETERAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL URETERAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL URETHRAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL URETHRAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL URETHRAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL AMBULATORY SURGICAL CENTER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 114. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 116. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 117. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 118. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 119. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 120. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 121. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 123. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 124. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 125. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 150. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 152. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 153. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 154. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 155. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 156. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 157. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 158. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 159. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 160. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 161. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. NATO NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 176. NATO NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. NATO NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 178. NATO NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 179. NATO NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 180. NATO NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 181. NATO NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 182. NATO NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. NATO NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 184. NATO NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 185. NATO NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 186. NATO NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. G7 NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 188. G7 NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 189. G7 NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 190. G7 NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 191. G7 NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 192. G7 NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 193. G7 NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 194. G7 NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 195. G7 NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 196. G7 NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 197. G7 NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 198. G7 NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. BRICS NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. BRICS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 201. BRICS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 202. BRICS NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 203. BRICS NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 204. BRICS NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 205. BRICS NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 206. BRICS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. BRICS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 208. BRICS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 209. BRICS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 210. BRICS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 226. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 227. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 228. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 229. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 230. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 232. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 233. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 234. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. GCC NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 236. GCC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 237. GCC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 238. GCC NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 239. GCC NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 240. GCC NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 241. GCC NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 242. GCC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 243. GCC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 244. GCC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 245. GCC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 246. GCC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 247. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 248. CHINA NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 249. CHINA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 250. CHINA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 251. CHINA NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 252. CHINA NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 253. CHINA NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 254. CHINA NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 255. CHINA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. CHINA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 257. CHINA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 258. CHINA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 259. CHINA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 269. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 270. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 271. UNITED STATES NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. JAPAN NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 275. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 276. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 277. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 278. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 279. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 281. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 282. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 283. JAPAN NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. INDIA NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. INDIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 286. INDIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 287. INDIA NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 288. INDIA NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 289. INDIA NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 290. INDIA NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 291. INDIA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. INDIA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 293. INDIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 294. INDIA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 295. INDIA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. GERMANY NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 299. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 300. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 301. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 302. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 303. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 305. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 306. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 307. GERMANY NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 320. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 322. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 323. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 324. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 325. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 326. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 327. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 328. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 329. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 330. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 331. AUSTRALIA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 332. FRANCE NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 333. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 334. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 335. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 336. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 337. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 338. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 339. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 340. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 341. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 342. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 343. FRANCE NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 344. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 345. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 346. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 347. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 348. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 349. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 350. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 351. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 352. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032 (USD MILLION)
TABLE 353. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2017-2032 (USD MILLION)
TABLE 354. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2017-2032 (USD MILLION)
TABLE 355. SOUTH KOREA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 356. ITALY NON-VASCULAR STENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 357. ITALY NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 358. ITALY NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 359. ITALY NON-VASCULAR STENTS MARKET SIZE, BY COVERAGE CONFIGURATION, 2017-2032 (USD MILLION)
TABLE 360. ITALY NON-VASCULAR STENTS MARKET SIZE, BY RETRIEVABILITY, 2017-2032 (USD MILLION)
TABLE 361. ITALY NON-VASCULAR STENTS MARKET SIZE, BY CONSTRUCTION METHOD, 2017-2032 (USD MILLION)
TABLE 362. ITALY NON-VASCULAR STENTS MARKET SIZE, BY CLINICAL INDICATION, 2017-2032 (USD MILLION)
TABLE 363. ITALY NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 364. ITALY NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2017-2032

Companies Mentioned

  • Abbott Laboratories
  • Allium Medical Solutions Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Changzhou Health Microport Medical Device Co., Ltd.
  • Coloplast A/S
  • CONMED Corporation
  • Cook Medical LLC
  • ELLA-CS, s.r.o.
  • Endo GI Medical Ltd.
  • Endo-Flex GmbH
  • Fujifilm Holdings Corporation
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Hoya Corporation
  • M.I.Tech Co., Ltd.
  • Medi-Globe GmbH
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Micro-Tech (Nanjing) Co., Ltd.
  • Olympus Corporation
  • Optimed Medizinische Instrumente GmbH
  • Pentax Medical
  • S.B. Kawasumi Laboratories, Inc.
  • Stening SRL
  • Taewoong Medical Co., Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Table Information